ID   CADO-LC9
AC   CVCL_Z053
SY   CADO LC9; Center for Adult Diseases Osaka-Lung Carcinoma 9
DR   Wikidata; Q54808357
RX   PubMed=7690355;
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
RX   PubMed=7690355; DOI=10.1111/j.1349-7006.1993.tb02040.x; PMCID=PMC5919213;
RA   Sakuma T., Kodama K., Hara T., Eshita Y., Shibata N., Matsumoto M.,
RA   Seya T., Mori Y.;
RT   "Levels of complement regulatory molecules in lung cancer:
RT   disappearance of the D17 epitope of CD55 in small-cell carcinoma.";
RL   Jpn. J. Cancer Res. 84:753-759(1993).
//
RX   PubMed=12569360; DOI=10.1038/sj.onc.1206106;
RA   Funakoshi T., Tachibana I., Hoshida Y., Kimura H., Takeda Y.,
RA   Kijima T., Nishino K., Goto H., Yoneda T., Kumagai T., Osaki T.,
RA   Hayashi S., Aozasa K., Kawase I.;
RT   "Expression of tetraspanins in human lung cancer cells: frequent
RT   downregulation of CD9 and its contribution to cell motility in small
RT   cell lung cancer.";
RL   Oncogene 22:674-687(2003).
//